 | • レポートコード：20QY06-06919 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、静脈内免疫グロブリン（IVIg）のグローバル市場について種類別（IVIg液体、IVIg粉末）、用途別（免疫不全、自己免疫疾患、急性感染症）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・静脈内免疫グロブリン（IVIg）市場の概要 ・世界の主要地域別静脈内免疫グロブリン（IVIg）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の静脈内免疫グロブリン（IVIg）市場規模2015-2026：種類別（IVIg液体、IVIg粉末） ・世界の静脈内免疫グロブリン（IVIg）市場規模2015-2026：用途別（免疫不全、自己免疫疾患、急性感染症） ・静脈内免疫グロブリン（IVIg）の北米市場規模2015-2020 ・静脈内免疫グロブリン（IVIg）のヨーロッパ市場規模2015-2020 ・静脈内免疫グロブリン（IVIg）の中国市場規模2015-2020 ・静脈内免疫グロブリン（IVIg）の日本市場規模2015-2020 ・静脈内免疫グロブリン（IVIg）の東南アジア市場規模2015-2020 ・静脈内免疫グロブリン（IVIg）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Baxter、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang） ・静脈内免疫グロブリン（IVIg）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・静脈内免疫グロブリン（IVIg）の市場動向・機会・課題 ・調査の結論 |
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.
North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.
Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Intravenous Immunoglobulin (IVIg) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intravenous Immunoglobulin (IVIg) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Intravenous Immunoglobulin (IVIg) industry.
Based on our recent survey, we have several different scenarios about the Intravenous Immunoglobulin (IVIg) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 9152.2 million in 2019. The market size of Intravenous Immunoglobulin (IVIg) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Intravenous Immunoglobulin (IVIg) Scope and Market Size
The global Intravenous Immunoglobulin (IVIg) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous Immunoglobulin (IVIg) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Intravenous Immunoglobulin (IVIg) market is segmented into
IVIg Liquid
IVIg Powder
Segment by Application, the Intravenous Immunoglobulin (IVIg) market is segmented into
Immunodeficiency
Autoimmune Disease
Acute Infection
The Intravenous Immunoglobulin (IVIg) market is analysed and market size information is provided by regions (countries). Segment by Application, the Intravenous Immunoglobulin (IVIg) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Intravenous Immunoglobulin (IVIg) Market Share Analysis
Intravenous Immunoglobulin (IVIg) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intravenous Immunoglobulin (IVIg) business, the date to enter into the Intravenous Immunoglobulin (IVIg) market, Intravenous Immunoglobulin (IVIg) product introduction, recent developments, etc.
The major vendors covered:
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
1 Intravenous Immunoglobulin (IVIg) Market Overview
1.1 Intravenous Immunoglobulin (IVIg) Product Scope
1.2 Intravenous Immunoglobulin (IVIg) Segment by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2020-2026)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Comparison by Application (2020-2026)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2026)
1.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2015-2026)
1.4.3 Global Intravenous Immunoglobulin (IVIg) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Intravenous Immunoglobulin (IVIg) Industry Impact
1.5.1 How the Covid-19 is Affecting the Intravenous Immunoglobulin (IVIg) Industry
1.5.1.1 Intravenous Immunoglobulin (IVIg) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Intravenous Immunoglobulin (IVIg) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Intravenous Immunoglobulin (IVIg) Players to Combat Covid-19 Impact
2 Intravenous Immunoglobulin (IVIg) Estimate and Forecast by Region
2.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2015-2020)
2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2015-2020)
2.3 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Intravenous Immunoglobulin (IVIg) Estimates and Projections (2015-2026)
2.4.2 Europe Intravenous Immunoglobulin (IVIg) Estimates and Projections (2015-2026)
2.4.3 China Intravenous Immunoglobulin (IVIg) Estimates and Projections (2015-2026)
2.4.4 Japan Intravenous Immunoglobulin (IVIg) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Intravenous Immunoglobulin (IVIg) Estimates and Projections (2015-2026)
2.4.6 India Intravenous Immunoglobulin (IVIg) Estimates and Projections (2015-2026)
3 Global Intravenous Immunoglobulin (IVIg) Competition Landscape by Players
3.1 Global Top Intravenous Immunoglobulin (IVIg) Players by Sales (2015-2020)
3.2 Global Top Intravenous Immunoglobulin (IVIg) Players by Revenue (2015-2020)
3.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2019)
3.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Company (2015-2020)
3.5 Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Intravenous Immunoglobulin (IVIg) Players (Opinion Leaders)
4 Global Intravenous Immunoglobulin (IVIg) Market Size by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Type (2015-2020)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2015-2020)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2014-2020)
4.2 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2021-2026)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2021-2026)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2021-2026)
5 Global Intravenous Immunoglobulin (IVIg) Market Size by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Application (2015-2020)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2015-2020)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2015-2020)
5.2 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2021-2026)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2021-2026)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2021-2026)
3 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures
3.2 North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
3.3 North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
3.4 North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
4 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures
4.2 Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
4.3 Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
4.4 Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
5 China Intravenous Immunoglobulin (IVIg) Market Facts & Figures
5.2 China Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
5.3 China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
5.4 China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
6 Japan Intravenous Immunoglobulin (IVIg) Market Facts & Figures
6.2 Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
6.3 Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
6.4 Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
7 Southeast Asia Intravenous Immunoglobulin (IVIg) Market Facts & Figures
7.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
8 India Intravenous Immunoglobulin (IVIg) Market Facts & Figures
8.2 India Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
8.3 India Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
8.4 India Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Intravenous Immunoglobulin (IVIg) Business
12.1 Baxter
12.1.1 Baxter Intravenous Immunoglobulin (IVIg) Corporation Information
12.1.2 Baxter Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
12.1.5 Baxter Recent Development
12.2 Grifols
12.2.1 Grifols Intravenous Immunoglobulin (IVIg) Corporation Information
12.2.2 Grifols Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
12.2.5 Grifols Recent Development
12.3 CSL
12.3.1 CSL Intravenous Immunoglobulin (IVIg) Corporation Information
12.3.2 CSL Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CSL Intravenous Immunoglobulin (IVIg) Products Offered
12.3.5 CSL Recent Development
12.4 Octapharma
12.4.1 Octapharma Intravenous Immunoglobulin (IVIg) Corporation Information
12.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
12.4.5 Octapharma Recent Development
12.5 Biotest
12.5.1 Biotest Intravenous Immunoglobulin (IVIg) Corporation Information
12.5.2 Biotest Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
12.5.5 Biotest Recent Development
12.6 Kedrion
12.6.1 Kedrion Intravenous Immunoglobulin (IVIg) Corporation Information
12.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
12.6.5 Kedrion Recent Development
12.7 Hualan Bio
12.7.1 Hualan Bio Intravenous Immunoglobulin (IVIg) Corporation Information
12.7.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
12.7.5 Hualan Bio Recent Development
12.8 CNBG
12.8.1 CNBG Intravenous Immunoglobulin (IVIg) Corporation Information
12.8.2 CNBG Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
12.8.5 CNBG Recent Development
12.9 Shanghai RAAS
12.9.1 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Corporation Information
12.9.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
12.9.5 Shanghai RAAS Recent Development
12.10 CBPO
12.10.1 CBPO Intravenous Immunoglobulin (IVIg) Corporation Information
12.10.2 CBPO Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
12.10.5 CBPO Recent Development
12.11 LFB Group
12.11.1 LFB Group Intravenous Immunoglobulin (IVIg) Corporation Information
12.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Products Offered
12.11.5 LFB Group Recent Development
12.12 BPL
12.12.1 BPL Intravenous Immunoglobulin (IVIg) Corporation Information
12.12.2 BPL Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 BPL Intravenous Immunoglobulin (IVIg) Products Offered
12.12.5 BPL Recent Development
12.13 Sichuan Yuanda Shuyang
12.13.1 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Corporation Information
12.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Business Overview and Total Revenue
12.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products Offered
12.13.5 Sichuan Yuanda Shuyang Recent Development
13 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
13.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
13.4 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Intravenous Immunoglobulin (IVIg) Distributors List
14.3 Intravenous Immunoglobulin (IVIg) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate by Type (2020-2026)
Table 2. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Intravenous Immunoglobulin (IVIg) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Intravenous Immunoglobulin (IVIg) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Intravenous Immunoglobulin (IVIg) Players to Combat Covid-19 Impact
Table 8. Global Market Intravenous Immunoglobulin (IVIg) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Region (2015-2020)
Table 10. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2015-2020)
Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Region (2015-2020)
Table 13. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Region (2021-2026)
Table 14. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Intravenous Immunoglobulin (IVIg) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Intravenous Immunoglobulin (IVIg) (K Bottle) of Key Companies (2015-2020)
Table 18. Global Intravenous Immunoglobulin (IVIg) Sales Share by Company (2015-2020)
Table 19. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Company (2015-2020)
Table 21. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2019)
Table 22. Global Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Company (2015-2020)
Table 23. Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites and Area Served
Table 24. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Intravenous Immunoglobulin (IVIg) Players
Table 27. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 28. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2015-2020)
Table 29. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Intravenous Immunoglobulin (IVIg) Price (K Bottle) by Type (2015-2020)
Table 31. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2021-2026)
Table 32. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2021-2026)
Table 34. Global Intravenous Immunoglobulin (IVIg) Price (K Bottle) by Type (2021-2026)
Table 35. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2015-2020)
Table 36. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2015-2020)
Table 37. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Intravenous Immunoglobulin (IVIg) Price (K Bottle) by Application (2015-2020)
Table 39. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2021-2026)
Table 40. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2021-2026)
Table 41. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2021-2026)
Table 43. Global Intravenous Immunoglobulin (IVIg) Price (K Bottle) by Application (2021-2026)
Table 44. United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2015-2020)
Table 45. United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
Table 46. United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 47. United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 48. United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2015-2020)
Table 49. United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 50. Europe Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2015-2020)
Table 51. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
Table 52. Europe Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 53. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 54. Europe Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2015-2020)
Table 55. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 56. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2015-2020)
Table 57. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
Table 58. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 59. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 60. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2015-2020)
Table 61. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 62. Japan Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2015-2020)
Table 63. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
Table 64. Japan Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 65. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 66. Japan Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2015-2020)
Table 67. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2015-2020)
Table 69. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 71. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 73. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 74. India Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2015-2020)
Table 75. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
Table 76. India Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 77. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 78. India Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2015-2020)
Table 79. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 80. Baxter Corporation Information
Table 81. Baxter Description and Business Overview
Table 82. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 83. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 84. Baxter Recent Development
Table 85. Grifols Corporation Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 88. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 89. Grifols Recent Development
Table 90. CSL Corporation Information
Table 91. CSL Description and Business Overview
Table 92. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 93. CSL Intravenous Immunoglobulin (IVIg) Product
Table 94. CSL Recent Development
Table 95. Octapharma Corporation Information
Table 96. Octapharma Description and Business Overview
Table 97. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 98. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 99. Octapharma Recent Development
Table 100. Biotest Corporation Information
Table 101. Biotest Description and Business Overview
Table 102. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 103. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 104. Biotest Recent Development
Table 105. Kedrion Corporation Information
Table 106. Kedrion Description and Business Overview
Table 107. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 108. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 109. Kedrion Recent Development
Table 110. Hualan Bio Corporation Information
Table 111. Hualan Bio Description and Business Overview
Table 112. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 113. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 114. Hualan Bio Recent Development
Table 115. CNBG Corporation Information
Table 116. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 117. CNBG Description and Business Overview
Table 118. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 119. CNBG Recent Development
Table 120. Shanghai RAAS Corporation Information
Table 121. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 122. Shanghai RAAS Description and Business Overview
Table 123. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 124. Shanghai RAAS Recent Development
Table 125. CBPO Corporation Information
Table 126. CBPO Description and Business Overview
Table 127. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 128. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 129. CBPO Recent Development
Table 130. LFB Group Corporation Information
Table 131. LFB Group Description and Business Overview
Table 132. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 133. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 134. LFB Group Recent Development
Table 135. BPL Corporation Information
Table 136. BPL Description and Business Overview
Table 137. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 138. BPL Intravenous Immunoglobulin (IVIg) Product
Table 139. BPL Recent Development
Table . Sichuan Yuanda Shuyang Corporation Information
Table . Sichuan Yuanda Shuyang Description and Business Overview
Table . Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table . Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table . Sichuan Yuanda Shuyang Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Intravenous Immunoglobulin (IVIg) Distributors List
Table 148. Intravenous Immunoglobulin (IVIg) Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Market Share by Application in 2020 & 2026
Figure 6. Immunodeficiency Examples
Figure 7. Autoimmune Disease Examples
Figure 8. Acute Infection Examples
Figure 9. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate (2015-2026)
Figure 10. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Intravenous Immunoglobulin (IVIg) Price Trends Growth Rate (2015-2026) (USD/Bottle)
Figure 12. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate (2015-2026)
Figure 16. Europe Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Intravenous Immunoglobulin (IVIg) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Intravenous Immunoglobulin (IVIg) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Intravenous Immunoglobulin (IVIg) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Intravenous Immunoglobulin (IVIg) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in Intravenous Immunoglobulin (IVIg) 2015 & 2019
Figure 27. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2015-2020)
Figure 29. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2015-2020)
Figure 31. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2019
Figure 33. United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2019
Figure 34. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Company in 2019
Figure 35. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2019
Figure 36. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2019
Figure 37. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Company in 2019
Figure 38. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2019
Figure 39. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2019
Figure 40. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Company in 2019
Figure 41. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2019
Figure 42. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2019
Figure 46. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Company in 2019
Figure 47. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2019
Figure 48. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2019
Figure 49. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Biotest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. CNBG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. CBPO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. LFB Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. BPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sichuan Yuanda Shuyang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure 64. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure 65. Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
ヒト免疫グロブリンの世界市場レポート2020 Market Analysis and Insights: Global Human Immunoglobulin Market The global Human Immunoglobulin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Human Immunoglobulin Scope and Market Size The global Human…- ヒト狂犬病免疫グロブリン（IM）の世界市場レポート2020 Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation …
- 免疫グロブリンELISAキットの世界市場レポート2020 Market Analysis and Insights: Global Immunoglobulin ELISA Kits Market The global Immunoglobulin ELISA Kits market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Immunoglobulin ELISA Kits Scope and Market Size T…
- ソリリス静脈内の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Soliris Intravenous market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Soliris Intravenous marke…
- 静脈フィルターの世界市場レポート2020 Market Analysis and Insights: Global Intravenous Filter Market The global Intravenous Filter market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Intravenous Filter Scope and Market Size The global Intravenous…